Sweden - HealthQuill

Eli Lilly and Company and Sweden’s Camurus AB have signed a $870 million pact to develop incretin products for diabetes and other chronic diseases.

Lilly, Sweden’s Camurus sign $870 million pact for incretin products

HQ Team June 4, 2025: Eli Lilly and Company and Sweden’s Camurus AB have signed a $870 million pact to develop incretin products.

by HealthQuill
June 4, 2025
0 Comments

Long-standing allies and new contributors have stepped up funding to the cash-strapped World Health Organization with a total of $170 million.

Drugs Health Pharma

Governments, philanthropic partners pledge $170 million to WHO

HQ Team May 21, 2025: Long-standing allies and new contributors have stepped up funding to the cash-strapped World Health Organization with a total.

by HealthQuill
May 21, 2025
0 Comments

Sweden’s researchers have recorded 300 times higher methane emissions in open patches of Siljan Ring lakes, the largest meteorite crater in Europe, raising climate concerns.

Climate Health Research

Europe’s largest meteorite crater’s methane output remains a mystery

HQ Team April 10, 2025: Sweden’s researchers have recorded 300 times higher methane emissions in open patches of Siljan Ring lakes, the largest.

by HealthQuill
April 10, 2025
0 Comments

FibroGen Inc., a US-based pharmaceutical company, will sell its China subsidiary to AstraZeneca Plc. for $160 million, allowing the Anglo-Swedish firm to gain access to an anaemia drug in the world’s most populated nation.

Drugs Health Pharma

AstraZeneca Plc buys China unit of FibroGen Inc for $160 million

HQ Team February 21, 2025: FibroGen Inc., a US-based pharmaceutical company, will sell its China subsidiary to AstraZeneca Plc. for $160 million, allowing.

by HealthQuill
February 21, 2025
0 Comments

AstraZeneca’s drug for treating limited-stage small cell lung cancer got a recommendation for approval from an EU regulator panel, according to the British-Swedish drugmaker.

Uncategorized

EU panel gives a positive opinion for AstraZeneca’s cancer drug

AstraZeneca’s drug for treating limited-stage small cell lung cancer got a recommendation for approval from an EU regulator panel, according to the British-Swedish.

by HealthQuill
February 3, 2025
0 Comments

The EU faces a new set of healthcare challenges potentially more potent than the Covid-19 pandemic, and some states are “miles away” from ensuring efficient preventive environments, according to a report from the independent Globsec.

Drugs Health Pharma

EU faces new healthcare threats, some states ‘miles away’ from ready

The EU faces a new set of healthcare challenges potentially more potent than the Covid-19 pandemic, and some states are “miles away” from.

by HealthQuill
November 2, 2024
0 Comments

China’s drug regulator, the National Medical Products Association, has approved AstraZeneca Plc’s asthma drug.

Drugs Health Pharma

AstraZeneca’s asthma drug gets regulator’s approval in China

China’s drug regulator, the National Medical Products Association, has approved AstraZeneca Plc’s asthma drug.

by HealthQuill
August 20, 2024
0 Comments

German biotechnology company, BioNTech SE announced a $ 90 million program in partnership with the Coalition for Epidemic Preparedness Innovations (CEPI) to develop a vaccine for mpox.

Drugs Health Medical

Sweden confirms first case of Mpox outside Africa

HQ Team August 15, 2024: Sweden confirmed its first case of the most virulent form of Mpox Thursday, a viral infection found in.

by HealthQuill
August 15, 2024
0 Comments

The Europen Union has approved AstraZeneca’s Tagrisso along with chemotherapy treatment for lung cancer patients after trials showed an extended nine months of survival.

Drugs Health Pharma

AstraZeneca’s medicine for non-small lung cancer gets EU nod

HQ Team July 5, 2024: The Europen Union has approved AstraZeneca’s Tagrisso along with chemotherapy treatment for lung cancer patients after trials showed.